tiprankstipranks
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
US Market
ZNTL
Zentalis Pharmaceuticals
RESEARCH TOOLSreports

Zentalis Pharmaceuticals (ZNTL) Financial Statements

375 Followers

Zentalis Pharmaceuticals Financial Overview

Zentalis Pharmaceuticals's market cap is currently $195.77M. The company's EPS TTM is $-0.5; its P/E ratio is -0.71; Zentalis Pharmaceuticals is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 67.42M$ 0.00$ 0.00$ 0.00
Gross Profit$ -739.00K$ 67.42M$ 0.00$ 0.00$ 0.00
Operating Income$ -146.25M$ -191.19M$ -299.51M$ -227.29M$ -216.54M
EBITDA$ -145.51M$ -186.17M$ -247.60M$ -225.86M$ -207.20M
Net Income$ -137.06M$ -165.84M$ -292.19M$ -236.81M$ -158.72M
Balance Sheet
Cash & Short-Term Investments$ 245.89M$ 371.08M$ 482.92M$ 437.37M$ 340.13M
Total Assets$ 288.97M$ 430.34M$ 562.03M$ 553.46M$ 472.02M
Total Debt$ 39.58M$ 42.65M$ 45.77M$ 47.33M$ 45.91M
Net Debt$ 3.58M$ 8.75M$ 17.73M$ 4.26M$ -14.04M
Total Liabilities$ 72.76M$ 93.15M$ 124.64M$ 119.43M$ 107.54M
Stockholders' Equity$ 216.20M$ 337.19M$ 437.28M$ 433.80M$ 363.95M
Cash Flow
Free Cash Flow$ -125.25M$ -171.08M$ -208.41M$ -166.30M$ -160.20M
Operating Cash Flow$ -125.25M$ -170.86M$ -207.82M$ -163.75M$ -154.09M
Investing Cash Flow$ 131.62M$ 176.56M$ -44.46M$ -114.18M$ -18.11M
Financing Cash Flow$ -4.28M$ 108.00K$ 237.30M$ 261.04M$ 178.52M
Currency in USD

Zentalis Pharmaceuticals Earnings and Revenue History

Income Statement >

Zentalis Pharmaceuticals Debt to Assets

Balance Sheet >

Zentalis Pharmaceuticals Cash Flow

Cash Flow >

Zentalis Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >